Researchers analyze Real-World use of prostate cancer drug in over 6,000 patients
NCT ID NCT07450157
First seen Mar 22, 2026 · Last updated May 14, 2026 · Updated 8 times
Summary
This study did not test a new treatment. Instead, researchers looked at the medical records of over 6,000 prostate cancer patients who received a drug called 177Lu-PSMA-617. They wanted to understand who got the drug, what treatments they had before, and how long they lived. The goal was to learn more about how this drug is used in real-world medical practice.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PROSTATE CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Novartis
East Hanover, New Jersey, 07936, United States
Conditions
Explore the condition pages connected to this study.